In a Perspective for the New England Journal of Medicine, Sarpatwari and Kesselheim discuss the future of follow-on biologics in the United States. Among other issues, the article discusses the impact that so-called carve-outs from state drug product selection laws will have on reducing the market penetration of interchangeable biologics.
Johns Hopkins University Bloomberg School of Public Health
A new study released on March 2, 2015, in Health Affairs reports that most primary care physicians are aware of prescription drug monitoring programs and have used the data in their practices, but do so only intermittently.
The study surveyed 420 physicians randomly identified through the American Medical Association’s Masterfile list. Of those physicians surveyed, 72 percent were aware of their state’s prescription drug monitoring program, and 53 percent reported that they had used the programs.
This study explores 24 legislative options in five categories currently being used by states. The paper also offers evidence-based suggestions within each category for how to impact the strength of the vaccination requirement and the number of exemptions.
Section 287(g) of the Immigration and Nationality Act allowed states and localities to enforce federal immigration laws. This study finds that the state-level enforcement of this law has had an adverse impact on the use of pregnancy and childcare-related health services by Hispanic and Latina women.
Tracking of infectious diseases is a public health core function essential to disease prevention and control. Each state mandates reporting of certain infectious diseases to public health authorities. These laws vary by state, and the variation could affect the ability to collect critical information.
The 2009 H1N1 influenza pandemic served as a case study to examine the legal authority in the 50 states; Washington, DC; and New York City for mandatory infectious disease reporting, particularly for influenza and new or emerging infectious diseases.
New Jersey (NJ) implemented the first Graduated Driver Licensing (GDL) decal provision in the U.S. in May 2010. An initial study reported a 1-year post-decal decrease in the crash rate among NJ intermediate drivers aged <21 years. Longer-term analysis is critical for policymakers in other states considering whether to implement a decal provision. This study, published in the American Journal of Public Health, evaluates the longer-term (2-year) effect of NJ’s decal provision on overall and age-specific crash rates of young drivers with intermediate licenses.
A study released in the American Journal of Public Health finds that young men in New York City who report they’ve been stopped and questioned by police are also reporting higher levels of trauma and stress associated with those experiences, particularly when they report that the encounters were intrusive.
A team from the LA Department of Health analyzed 20 different documents broadly defined as “joint use agreements.” The findings are displayed in this report, which provides a snapshot of the relative strengths and weaknesses of all 20 agreements through analysis and case studies from neighborhoods in the Los Angeles area.